Skip to main content
. 2023 Sep 15;18(12):1573–1582. doi: 10.2215/CJN.0000000000000295

Table 3.

Prognostic factors associated with kidney survival

Parameter Unadjusted Survival Analysis Multivariable Analysis
Hazard Ratio (95% CI) Hazard Ratio (95% CI)
Age, yr 1.02 (0.98 to 1.06)
Male 1.35 (0.58 to 3.12)
24-h urine protein, g/24 h 1.02 (0.96 to 1.09)
Urine red blood cells, per µl 1.00 (1.00 to 1.00)
Serum albumin, g/dl 0.52 (0.24 to 1.12)
Serum creatinine at biopsy, mg/dla,b 1.55 (1.27 to 1.89) 1.47 (1.15 to 1.87)c
Hemoglobin, g/La,b 0.97 (0.95 to 0.99)
Detection of clone 0.62 (0.21 to 1.87)
Percentage of global glomerulosclerosis, %a,b 1.06 (1.02 to 1.10) 1.05 (1.01 to 1.10)d
Percentage of crescents, %a,b 1.04 (1.00 to 1.07)
Bortezomib-based chemotherapyb 0.52 (0.19 to 1.41)
Urinary C3a/creatinine, ng/mg 1.00 (1.00 to 1.00)
Urinary C5a/creatinine, ng/mg 1.00 (1.00 to 1.00)
Urinary sC5b-9/creatinine, g/mga,b 1.00 (1.00 to 1.00)
Urinary C4d/creatinine, µg/mga,b 1.39 (1.11 to 1.75) 1.36 (1.00 to 1.83)e
Urinary C1q/creatinine, ng/mg 1.04 (0.93 to 1.16)
Urinary MBL/creatinine, ng/mg 1.01 (1.00 to 1.02)
Urinary Bb/creatinine, µg/mga,b 1.06 (1.01 to 1.11)
Plasma C3a, ng/ml 1.00 (1.00 to 1.00)
Plasma C5a, ng/ml 1.00 (1.00 to 1.00)
Plasma sC5b-9, ng/ml 1.00 (1.00 to 1.00)
Plasma C4d, µg/ml 1.07 (0.98 to 1.16)
Plasma C1q, ng/ml 1.00 (1.00 to 1.00)
Plasma MBL, ng/ml 1.00 (1.00 to 1.00)
Plasma Bb, µg/ml 1.19 (0.69 to 2.06)
Intensity of global C3ca,b 1.07 (1.00 to 1.13)
Intensity of global C5b-9×100 1.03 (0.73 to 1.46)
Intensity of global C4d×100 1.15 (0.94 to 1.40)
Intensity of global C1q 1.06 (0.97 to 1.15)
Intensity of global MBL 0.63 (0.18 to 2.18)
Intensity of global Bb 1.09 (0.80 to 1.49)

CI, confidence interval; sC5b-9, soluble C5b-9; MBL, mannose-binding lectin.

a

In unadjusted survival analysis, P < 0.05.

b

Variables were incorporated into multivariable Cox regression.

c

In multivariable analysis, P = 0.002.

d

In multivariable analysis, P = 0.01.

e

In multivariable analysis, P = 0.05.